In the case of the platelet-secreted cytokine TGF-β, ligands from the TGF-β family can trigger signaling pathways in tumor cells that either prevent or promote carcinogenesis, depending on the stage of the disease and type of cancer. This evidence concerns the gene TGFB1 and cancer.